TG Therapeutics | TGTX - Trade Creditors

Stock Price
30.90
Daily Change
1.24 4.18%
Monthly
0.32%
Yearly
8.31%
Q1 Forecast
28.61

TG Therapeutics reported $61.64M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Ardelyx USD 18.39M 3.29M Sep/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Bayer EUR 6.38B 343M Sep/2025
Biogen USD 432M 18.9M Dec/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Curis USD 4.1M 1.01M Jun/2025
Gilead Sciences USD 808M 226M Sep/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
J&J USD 11.99B 2.37B Dec/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novavax USD 15.23M 35.37M Sep/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Verastem USD 7.2M 3.17M Mar/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025